Crosstalk between liver antioxidant and the endocannabinoid systems after chronic administration of the FAAH inhibitor, URB597, to hypertensive rats

Toxicology and Applied Pharmacology

Volumn 301, Issue , 2016, Pages 31-41

  Biernacki, Michał ^a   Łuczaj, Wojciech ^a   Gegotek, Agnieszka ^a   Toczek, Marek ^a   Bielawska, Katarzyna ^a   Skrzydlewska, Elzbieta ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Endocannabinoid system; Hypertension; Liver; Oxidative stress; URB597

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ACYLGLYCEROL LIPASE; ALPHA TOCOPHEROL; ANANDAMIDE; ANTIOXIDANT; ASCORBIC ACID; CANNABINOID 1 RECEPTOR; CASPASE; CYCLOHEXYLCARBAMIC ACID 3' CARBAMOYLBIPHENYL 3 YL ESTER; DEOXYCORTICOSTERONE ACETATE; DNA; ENDOCANNABINOID; FATTY ACID AMIDASE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; LIPID; N ARACHIDONOYL DOPAMINE; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG; AMIDASE; BENZAMIDE DERIVATIVE; CARBAMIC ACID DERIVATIVE; CATALASE; CYCLOHEXYL CARBAMIC ACID 3'-CARBAMOYLBIPHENYL-3-YL ESTER; FATTY-ACID AMIDE HYDROLASE; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE TRANSFERASE; PHOSPHOLIPASE A2; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DEOXYCORTICOSTERONE-SALT INDUCED HYPERTENSION; ENZYME ACTIVITY; HYPERTENSION; LIVER FUNCTION; LONG TERM CARE; MALE; MOLECULAR INTERACTION; NONHUMAN; PROTEIN EXPRESSION; RAT; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMICALLY INDUCED; DRUG EFFECTS; LIVER; METABOLISM; WISTAR RAT;

AMIDOHYDROLASES; ANIMALS; BENZAMIDES; CARBAMATES; CATALASE; DESOXYCORTICOSTERONE ACETATE; ENDOCANNABINOIDS; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; HYPERTENSION; LIVER; MALE; MONOACYLGLYCEROL LIPASES; PHOSPHOLIPASES A2; RATS, WISTAR; REACTIVE OXYGEN SPECIES; RECEPTOR, CANNABINOID, CB1; SUPEROXIDE DISMUTASE;

EID: 84963759274     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2016.04.006     Document Type: Article

References (80)

1. Aebi H. Catalase in vitro. Methods Enzymol. 1984, 105:121-126.
2. Ayala A., Muñoz M.F., Argüelles S. Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxidative Med. Cell. Longev. 2014, 2014:360438. 10.1155/2014/360438.
3. Basu P.P., Aloysius M.M., Shah N.J., Brown R.S. Review article: the endocannabinoid system in liver disease, a potential therapeutic target. Aliment. Pharmacol. Ther. 2014, 39:790-801.
4. Bátkai S., Pacher P., Osei-Hyiaman D., Radaeva S., Liu J., Harvey-White J., Offertáler L., Mackie K., Rudd M.A., Bukoski R.D., Kunos G. Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension. Circulation 2004, 110:1996-2002.
5. Bosch-Morell F., Flohe L., Marin N., Romero F.J. 4-Hydroxynonenal inhibits glutathione peroxidase: protection by glutathione. Free Radic. Biol. Med. 1999, 26:1383-1387.
6. Briones A.M., Touyz R.M. Oxidative stress and hypertension: current concepts. Curr. Hypertens. Rep. 2010, 12:135-142.
7. Bruno R.S., Leonard S.W., Atkinson J., Montine T.J., Ramakrishnan R., Bray T.M., Traber M.G. Faster plasma vitamin E disappearance in smokers is normalized by vitamin C supplementation. Free Radic. Biol. Med. 2006, 40:689-697.
8. Callera G.X., Tostes R.X., Yogi A., Montezano A.X.X., Touyz R.M. Endothelin-1-induced oxidative stress in DOCA-salt hypertension involves NADPH-oxidase-independent mechanisms. Clin. Sci. 2006, 110:243-253.
9. Cao Z., Mulvihill M.M., Mukhopadhyay P., Xu H., Erdélyi K., Hao E., Holovac E., Haskó G., Cravatt B.F., Nomura D.K., Pacher P. Monoacylglycerol lipase controls endocannabinoid and eicosanoid signaling and hepatic injury in mice. Gastroenterology 2013, 144:808-817.
10. Caraceni P., Pertosa A.M., Giannone F., Domenicali M., Grattagliano I., Principe A., Mastroleo C., Perrelli M.G., Cutrin J., Trevisani F., Croci T., Bernardi M. Antagonism of the cannabinoid CB-1 receptor protects rat liver against ischaemia-reperfusion injury complicated by endotoxaemia. Gut 2009, 58:1135-1143.
11. Chambel S.S., Santos-Gonçalves A., Duarte T.L. The dual role of Nrf2 in nonalcoholic fatty liver disease: regulation of antioxidant defenses and hepatic lipid metabolism. Biomed. Res. Int. 2015, 2015:597134. 10.1155/2015/597134.
12. Chelladurai P., Seeger W., Pullamsetti S.S. Matrix metalloproteinases and their inhibitors in pulmonary hypertension. Eur. Respir. J. 2012, 40:766-782.
13. Chen X., Touyz R.M., Park J.B., Schiffrin E.L. Antioxidant effects of vitamins C and E are associated with altered activation of vascular NADPH oxidase and superoxide dismutase in stroke-prone SHR. Hypertension 2001, 38:606-611.
14. Christie W.W. Preparation of ester derivatives of fatty acids for chromatographic analysis. Advances in Lipid Methodology - Two 1993, 69-111. Oily Press, Dundee. W.W. Christie (Ed.).
15. Coolen S.A., Van Buuren B., Duchateau G., Upritchard J., Verhagen H. Kinetics of biomarkers: biological and technical validity of isoprostanes in plasma. Amino Acids 2005, 29:429-436.
16. De Morrow S., Francis H., Gaudio E., Ueno Y., Venter J., Onori P., Franchitto A., Vaculin B., Vaculin S., Alpini G. Anandamide inhibits cholangiocyte hyperplastic proliferation via activation of thioredoxin 1/redox factor 1 and AP-1 activation. Am. J. Physiol. Gastrointest. Liver Physiol. 2008, 294:G506-G519.
17. DeLeve L.D., Wang X., Kanel G.C., Atkinson R.D., McCuskey R.S. Prevention of hepatic fibrosis in a murine model of metabolic syndrome with nonalcoholic steatohepatitis. Am. J. Pathol. 2008, 173:993-1001.
18. Di Marzo V., Maccarrone M. FAAH and anandamide: is 2-AG really the odd one out?. Trends Pharmacol. Sci. 2008, 29:229-233.
19. Diesen D.L., Kuo P.C. Nitric oxide and redox regulation in the liver: part II. Redox biology in pathologic hepatocytes and implications for intervention. J. Surg. Res. 2011, 167:96-112.
20. Dizdaroglu M., Jaruga P., Rodriguez H. Measurement of 8-hydroxy-2'-deoxyguanosine in DNA by high performance liquid chromatography-mass spectrometry: comparison with measurement by gas chromatography-mass spectrometry. Nucleic Acids Res. 2001, 29.
21. Eissa S., Seada L.S. Quantitation of bcl-2 protein in bladder cancer tissue by enzyme immunoassay: comparison with Western blot and immunohistochemistry. Clin. Chem. 1998, 44:1423-1429.
22. Elmarakby A.A., Quigley J.E., Imig J.D., Pollock J.S., Pollock D.M. TNF-α inhibition reduces renal injury in DOCA-salt hypertensive rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2008, 294:R76-R83.
23. Engeli S., Blüher M., Jumpertz R., Wiesner T., Wirtz H., Bosse-Henck A., Stumvoll M., Batkai S., Pacher P., Harvey-White J., Kunos G., Jordan J. Circulating anandamide and blood pressure in patients with obstructive sleep apnea. J. Hypertens. 2012, 30:2345-2351.
24. Godlewski G., Alapafuja S.O., Bátkai S., Nikas S.P., Cinar R., Offertáler L., Osei-Hyiaman D., Liu J., Mukhopadhyay B., Harvey-White J., Tam J., Pacak K., Blankman J.L., Cravatt B.F., Makriyannis A., Kunos G. Inhibitor of fatty acid amide hydrolase normalizes cardiovascular function in hypertension without adverse metabolic effects. Chem. Biol. 2010, 17:1256-1266.
25. Gómez-Guzmán M., Jiménez R., Sánchez M., Zarzuelo M.J., Galindo P., Quintela A.N., López-Sepúlveda R., Romero M., Tamargo J., Vargas F., Pérez-Vizcaíno F., Duarte J. Epicatechin lowers blood pressure, restores endothelial function, and decreases oxidative stress and endothelin-1 and NADPH oxidase activity in DOCA-salt hypertension. Free Radic. Biol. Med. 2012, 52:70-79.
26. Griendling K.K., Minieri C.A., Ollerenshaw J.D., Alexander R.W. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ. Res. 1994, 74:1141-1148.
27. Habig W.H., Pabst M.J., Jakoby W.B. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J. Biol. Chem. 1974, 249:7130-7139.
28. Han K.H., Lim S., Ryu J., Lee C.W., Kim Y., Kang J.H., Kang S.S., Ahn Y.K., Park C.S., Kim J.J. CB1 and CB2 cannabinoid receptors differentially regulate the production of reactive oxygen species by macrophages. Cardiovasc. Res. 2009, 84:378-386.
29. Hao X., Chen J., Luo Z., He H., Yu H., Ma L., Ma S., Zhu T., Liu D. TRPV1 activation prevents high-salt diet-induced nocturnal hypertension in mice. Pflugers Arch. - Eur. J. Physiol. 2011, 461:345-353.
30. Hemalatha G., Pugalendi K.V., Saravanan R. Modulatory effect of sesamol on DOCA-salt-induced oxidative stress in uninephrectomized hypertensive rats. Mol. Cell. Biochem. 2013, 379:255-265.
31. Ivanović D., Popović A., Radulović D., Medenica M. Reversed-phase ion-pair HPLC determination of some water soluble vitamins in pharmaceuticals. J. Pharm. Biomed. Anal. 1999, 18:999-1004.
32. Jia J., Ma L., Wu M., Zhang L., Zhang X., Zhai Q., Jiang T., Wang Q., Xiong L. Anandamide protects HT22 cells exposed to hydrogen peroxide by inhibiting CB1 receptor-mediated type 2 NADPH oxidase. Oxidative Med. Cell. Longev. 2014, 2014:893516. 10.1155/2014/893516.
33. Kasap S., Gönenç A., Sener D.E., Hisar I. Serum cardiac markers in patients with acute myocardial infarction: oxidative stress, C-reactive protein and N-terminal probrain natriuretic Peptide. J. Clin. Biochem. Nutr. 2007, 41:50-57.
34. Kinsey S.G., Naidu P.S., Cravatt B.F., Dudley D.T., Lichtman A.H. Fatty acid amide hydrolase blockade attenuates the development of collagen-induced arthritis and related thermal hyperalgesia in mice. Pharmacol. Biochem. Behav. 2011, 99:718-725.
35. Kobayashi A., Kang M., Okawa H., Ohtsuji M., Zenke Y., Chiba T., Igarashi K., Yamamoto M. Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Mol. Cell. Biol. 2004, 24:7130-7139.
36. Komatsu M., Kurokawa H., Waguri S., Taguchi K., Kobayashi A., Ichimura Y., Sou Y.S., Ueno I., Sakamoto A., Tong K.I., Kim M., Nishito Y., Iemura S., Natsume T., Ueno T., Kominami E., Motohashi H., Tanaka K., Yamamoto M. The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1. Nat. Cell Biol. 2010, 12:213-223.
37. Kreuz S., Siegmund D., Rumpf J.J., Samel D., Leverkus M., Janssen O., Häcker G., Dittrich-Breiholz O., Kracht M., Scheurich P., Wajant H. NFκB activation by Fas is mediated through FADD, caspase-8, and RIP and is inhibited by FLIP. J. Cell Biol. 2004, 166:369-380.
38. Kuzkaya N., Weissmann N., Harrison D.G., Dikalov S. Interactions of peroxynitrite, tetrahydrobiopterin, ascorbic acid, and thiols: implications for uncoupling endothelial nitricoxide synthase. J. Biol. Chem. 2003, 278:22546-22554.
39. Lam P.M., Marczylo T.H., El-Talatini M., Finney M., Nallendran V., Taylor A.H., Konje J.C. Ultra performance liquid chromatography tandem mass spectrometry method for the measurement of anandamide in human plasma. Anal. Biochem. 2008, 380:195-201.
40. Landmesser U., Dikalov S., Price S.R., McCann L., Fukai T., Holland S.M., Mitch W.E., Harrison D.G. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J. Clin. Invest. 2003, 111:1201-1209.
41. Lerman L.O., Nath K.A., Rodriguez-Porcel M., Krier J.D., Schwartz R.S., Napoli C., Romero J.C. Increased oxidative stress in experimental renovascular hypertension. Hypertension 2001, 37:541-546.
42. Levine R.L., Garland D., Oliver C.N., Amici A., Climent I., Lenz A.G., Ahn B.W., Shaltiel S., Stadtman E.R. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol. 1990, 186:464-478.
43. Levonen A.L., Landar A., Ramachandran A., Ceaser E.K., Dickinson D.A., Zanoni G., Morrow J.D., Darley-Usmar V.M. Cellular mechanisms of redox cell signalling: role of cysteine modification in controlling antioxidant defences in response to electrophilic lipid oxidation products. Biochem. J. 2004, 378:373-382.
44. Li D., Chen B.M., Peng J., Zhang Y.S., Li X.H., Yuan Q., Hu C.P., Deng H.W., Li Y.J. Role of anandamide transporter in regulating calcitonin gene-related peptide production and blood pressure in hypertension. J. Hypertens. 2009, 27:1224-1232.
45. Li H., Wood J.T., Whitten K.M., Vadivel S.K., Seng S., Makriyannis A., Avraham H.K. Inhibition of fatty acid amide hydrolase activates Nrf2 signalling and induces heme oxygenase 1 transcription in breast cancer cells. Br. J. Pharmacol. 2013, 170:489-505.
46. Liu W., Kato M., Akhand A.A., Hayakawa A., Suzuki H., Miyata T., Kurokawa K., Hotta Y., Ishikawa N., Nakashima I. 4-Hydroxynonenal induces a cellular redox status-related activation of the caspase cascade for apoptotic cell death. J. Cell Sci. 2000, 113:635-641.
47. Luo X.P., Yazdanpanah M., Bhooi N., Lehotay D.C. Determination of aldehydes and other lipid peroxidation products in biological samples by gas chromatography-mass spectrometry. Anal. Biochem. 1995, 228:294-298.
48. Maeso N., Garcia-Martinez D., Ruperez F.J., Cifuentes A., Barbas C. Capillary electrophoresis of glutathione to monitor oxidative stress and response to antioxidant treatments in an animal model. J. Chromatogr. B 2005, 822:61-69.
49. Mallat A., Teixeira-Clerc F., Lotersztajn S. Cannabinoid signaling and liver therapeutics. J. Hepatol. 2013, 59:891-896.
50. Maruyama A., Nishikawa K., Kawatani Y., Mimura J., Hosoya T., Harada N., Yamamato M., Itoh K. The novel Nrf2-interacting factor KAP1 regulates susceptibility to oxidative stress by promoting the Nrf2-mediated cytoprotective response. Biochem. J. 2011, 436:387-397.
51. Mertens K., Lowes D.A., Webster N.R., Talib J., Hall L., Davies M.J., Beattie J.H., Galley H.F. Low zinc and selenium concentrations in sepsis are associated with oxidative damage and inflammation. Br. J. Anaesth. 2015, 114:990-999.
52. Miller A.M., Masrorpour M., Klaus C., Zhang J.X. Endothelin-1 induced activation of cytosolic phospholipase A2 and thromboxane A2 production in sequential hepatic stresses: potential role in portal hypertension. J. Hepatol. 2007, 46:276-285.
53. Mize C.E., Langdon R.G. Hepatic glutathione reductase. Purification and general kinetic properties. J. Biol. Chem. 1962, 237:1589-1595.
54. Montuschi P., Barnes P.J., Roberts L.J. Isoprostanes: markers and mediators of oxidative stress. FASEB J. 2004, 18:1791-1800.
55. Mukhopadhyay P., Rajesh M., Bátkai S., Patel V., Kashiwaya Y., Liaudet L., Evgenov O.V., Mackie K., Haskó G., Pacher P. CB1 cannabinoid receptors promote oxidative stress and cell death in murine models of doxorubicin-induced cardiomyopathy and in human cardiomyocytes. Cardiovasc. Res. 2010, 85:773-784.
56. Muriel P. Role of free radicals in liver diseases. Hepatol. Int. 2009, 3:526-536.
57. Murphy N., Cowley T.R., Blau C.W., Dempsey C.N., Noonan J., Gowran A., Tanveer R., Olango W.M., Finn D.P., Campbell V.A., Lynch M.A. The fatty acid amide hydrolase inhibitor URB597 exerts anti-inflammatory effects in hippocampus of aged rats and restores an age-related deficit in long-term potentiation. J. Neuroinflammation 2012, 9:79. 10.1186/1742-2094-9-79.
58. Osei-Hyiaman D., DePetrillo M., Pacher P., Liu J., Radaeva S., Bátkai S., Harvey-White J., Mackie K., Offertáler L., Wang L., Kunos G. Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity. J. Clin. Invest. 2005, 115:1298-1305.
59. Page S., Fischer C., Baumgartner B., Haas M., Kreusel U., Loidl G., Hayn M., Ziegler-Heitbrock H.W., Neumeier D., Brand K. 4-Hydroxynonenal prevents NF-kappaB activation and tumor necrosis factor expression by inhibiting IkappaB phosphorylation and subsequent proteolysis. J. Biol. Chem. 1999, 274:11611-11618.
60. Paglia D.E., Valentine W.N. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J. Lab. Clin. Med. 1967, 70:158-169.
61. Prajda N., Weber G. Malignant transformation-linked imbalance: decreased xanthine oxidase activity in hepatomas. FEBS Lett. 1975, 59:245-259.
62. Reynolds L.J., Hughes L.L., Yu L., Dennis E.A. 1-Hexadecyl-2-arachidonoylthio-2-deoxy-sn-glycero-3-phosphorylcholine as a substrate for the microtiterplate assay of human cytosolic phospholipase A2. Anal. Biochem. 1994, 217:25-32.
63. Rice-Evans C.A., Diplock A.T., Symons M.C.R. Techniques in free radicals research. Laboratory techniques in biochemistry and molecular biology 1991, Amsterdam, Elsevier. R.H. Burdon, P.H. van Knippenberg (Eds.).
64. Rushworth S.A., Zaitseva L., Murray M.Y., Shah N.M., Bowles K.M., MacEwan D.J. The high Nrf2 expression in human acute myeloid leukemia is driven by NF-κB and underlies its chemo-resistance. Blood 2012, 120:5188-5198.
65. Sampey B.P., Carbone D.L., Doorn J.A., Drechsel D.A., Petersen D.R. 4-Hydroxy-2-nonenal adduction of extracellular signal-regulated kinase (Erk) and the inhibition of hepatocyte Erk-Est-like protein-1-activating protein-1 signal transduction. Mol. Pharmacol. 2007, 71:871-883.
66. Sarzani R., Forleo C., Pietrucci F., Capestro A., Soura E., Guida P., Sorrentino S., Iacoviello M., Romito R., Dessì-Fulgheri P., Pitzalis M., Rappelli A. The 212A variant of the APJ receptor gene for the endogenous inotrope apelin is associated with slower heart failure progression in idiopathic dilated cardiomyopathy. J. Card. Fail. 2007, 13:521-529.
67. Schupp N., Kolkhof P., Queisser N., Gärtner S., Schmid U., Kretschmer A., Hartmann E., Oli R.G., Schäfer S., Stopper H. Mineralocorticoid receptor-mediated DNA damage in kidneys of DOCA-salt hypertensive rats. FASEB J. 2011, 25:968-978.
68. Shacter E. Quantification and significance of protein oxidation in biological samples. Drug Metab. Rev. 2000, 32:307-326.
69. 2. Free Radic. Biol. Med. 2003, 34:521-530.
70. Siegmund S.V., Seki E., Osawa Y., Uchinami H., Cravatt B.F., Schwabe R.F. Fatty acid amide hydrolase determines anandamide induced cell death in the liver. J. Biol. Chem. 2006, 281:10431-10438.
71. Siegmund S.V., Wojtalla A., Schlosser M., Zimmer A., Singer M.V. Fatty acid amide hydrolase but not monoacyl glycerol lipase controls cell death induced by the endocannabinoid 2-arachidonoyl glycerol in hepatic cell populations. Biochem. Biophys. Res. Commun. 2013, 437:48-54.
72. Silvestri C., Ligresti A., Di Marzo V. Peripheral effects of the endocannabinoid system in energy homeostasis: adipose tissue, liver and skeletal muscle. Rev. Endocr. Metab. Disord. 2011, 12:153-162.
73. Sun Y., Tsuboi K., Okamoto Y., Tonai T., Murakami M., Kudo I., Ueda N. Biosynthesis of anandamide and N-palmitoylethanolamine by sequential actions of phospholipase A2 and lysophospholipase D. Biochem. J. 2004, 380:749-756.
74. Sykes J.A., McCormac F.X., O'Breien T.J. Preliminary study of the superoxide dismutase content of some human tumors. Cancer Res. 1978, 38:2759-2762.
75. Toczek M., Baranowska-Kuczko M., Grzeda E., Pedzińska-Betiuk A., Weresa J., Malinowska B. Age-specific influences of chronic administration of the fatty acid amide hydrolase inhibitor URB597 on cardiovascular parameters and organ hypertrophy in DOCA-salt hypertensive rats. Pharmacol. Rep. 2016, 68:363-369.
76. Tourino C., Oveisi F., Lockney J., Piomelli D., Maldonado R. FAAH deficiency promotes energy storage and enhances the motivation for food. Int. J. Obes. 2010, 34:557-568.
77. Uchida K., Shiraishi M., Naito Y., Torii Y., Nakamura Y., Osawa T. Activation of stress signaling pathways by the end product of lipid peroxidation. 4-Hydroxy-2-nonenal is a potential inducer of intracellular peroxide production. J. Biol. Chem. 1999, 274:2234-2242.
78. Ulloa N.M., Deutsch D.G. Assessment of a spectrophotometric assay for monoacylglycerol lipase activity. AAPS J. 2010, 12:197-201.
79. Vatassery G.T., Brin M.F., Fahn S., Kayden H.J., Traber M.G. Effect of high doses of dietary vitamin E on the concentrations of vitamin E in several brain regions, plasma, liver, and adipose tissue of rats. J. Neurochem. 1988, 512:621-623.
80. Xu C., Yuan X., Pan Z., Shen G., Kim J.H., Yu S., Khor T.O., Li W., Ma J., Kong A.N. Mechanism of action of isothiocyanates: the induction of ARE-regulated genes is associated with activation of ERK and JNK and the phosphorylation and nuclear translocation of Nrf2. Mol. Cancer Ther. 2006, 5:1918-1926.